Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease by Gonçalo da Costa (198731)

“…Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. …”

IL-15 decreases angiogenesis <i>in vivo</i>. by Krizia Rohena-Rivera (3906838)

Decreased survival of HL60 cells after fractionated irradiation. by Annette Geltmeier (779536)

Activated caspase-3 decreases following CO exposure. by Ying Cheng (288456)

Numbers of neuroblasts are decreased in LCMV-cgPi mice. by Tony Sun (560139)

DISC1 expression decreases in the course of oligodendrocyte differentiation. by Tsuyoshi Hattori (254566)

Rab14 overexpression decreases phagocytosis of the malaria parasite. by Elsa Seixas (76018)

Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

“…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”

Selected point mutations of AhR and ARNT decrease PAS-A and/or PAS-B DNA-binding ability of ligand-activated AhR/ARNT dimer. by Dario Corrada (1880218)

HCV infection decreases MIN6 cell viability. by Qian Wang (32718)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Participants characteristics. by Sakiko Fukui (387048)

Subjects:

Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)

Study selection criteria. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

PRISMA flow chart. by Filip Stanicic (17808254)

“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”

Estimates of the survival function (a) and kernel estimate of the hazard function (b) with points of greatest decrease. by Iveta Selingerová (849472)

“…<p>Estimates of the survival function (a) and kernel estimate of the hazard function (b) with points of greatest decrease.…”

Comparison of disability score means by obesity status^a. by Clémence Bussière (617221)

Elevated PE level in yeast decreases the sensitivity of replicating tombusvirus RNA to the reconstituted RNAi. by Nikolay Kovalev (184967)

“…Note that AGO1 and DCR1 were continuously expressed during the entire yeast culturing process to enhance RNAi activities in both strains. See <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1006520#ppat.1006520.g001" target="_blank">Fig 1A</a> for further details. …”

Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

“…(L) Quantitative RT-PCR showing the expression level of several flow-responsive genes after lidocaine treatment. <i>klf2a</i> expression is significantly decreased after 6 and 10 h of treatment and is restored by incubation at 34°C; 100% of expression corresponds to a normal expression level. …”